Prab: CSV import

2025-02-16T16:32:16Z

CSV import

← Older revision		Revision as of 16:32, 16 February 2025
Line 1:		Line 1:
	'''Glypican 3''' (~~'''~~GPC3~~'''~~) ~~is a [[protein]] that in humans is encoded by the ''GPC3'' [[gene]]. It~~ is a member of the [[glypican]] family~~, a group~~ of [[heparan sulfate~~]] [[~~proteoglycans]] that are attached to the ~~membrane by~~ a ~~[[Glycosylphosphatidylinositol\|~~glycosylphosphatidylinositol]] (GPI) anchor. ~~Glypican 3 plays a significant role~~ in [[cell growth~~]], [[cell~~ differentiation]], and ~~[[cell division]]~~, and is ~~involved in~~ the ~~regulation~~ of ~~[[Wnt signaling pathway\|Wnt signaling]]~~ and ~~[[Hedgehog signaling pathway\|Hedgehog signaling]] pathways. These pathways~~ are ~~critical~~ for ~~normal [[embryonic development]] and have been implicated in the development of various [[cancer]]s when dysregulated~~.		== Glypican-3 ==

			[[File:Schematic_of_the_glypican-3_protein..tif\|thumb\|right\|Schematic of the glypican-3 protein]]

			'''Glypican-3''' (GPC3) is a member of the glypican family of heparan sulfate proteoglycans that are attached to the cell surface via a glycosylphosphatidylinositol (GPI) anchor. Glypicans are involved in the regulation of cell growth and differentiation, and GPC3, in particular, has been implicated in various biological processes and diseases.

			== Structure ==

			Glypican-3 is composed of a core protein to which heparan sulfate chains are attached. The protein is anchored to the cell membrane by a GPI anchor. The schematic representation of the glypican-3 protein shows its modular structure, including the N-terminal and C-terminal domains, which are important for its function.

	== Function ==		== Function ==
	~~Glypican 3 is primarily expressed~~ in the [[~~liver~~]], [[~~kidney~~]], and [[~~lung~~]]~~, and is involved in the modulation of cell growth and proliferation~~. It acts as a co-receptor ~~for~~ growth factors ~~and modulates signaling pathways that are crucial for [[embryogenesis]] and [[organogenesis]]. In~~ the ~~liver, GPC3 has been shown to play a role in controlling [[~~cell ~~proliferation]]~~ and ~~in the suppression of [[Hepatocellular carcinoma\|hepatocellular carcinoma]] (HCC), the most common type of liver cancer~~.
			GPC3 plays a crucial role in modulating the activity of growth factors such as [[Wnt]], [[Hedgehog]], and [[Fibroblast growth factor\|FGF]]. It acts as a co-receptor, facilitating the interaction of these growth factors with their respective receptors on the cell surface. This modulation is essential for normal embryonic development and tissue homeostasis.

	== Clinical Significance ==		== Clinical Significance ==
	The loss of GPC3 function has been associated with [[Simpson-Golabi-Behmel syndrome]], a rare genetic condition characterized by pre- and postnatal overgrowth, [[facial dysmorphism]], and an increased risk of developing embryonal tumors, including [[Wilms' tumor]], hepatoblastoma, and neuroblastoma. Conversely, overexpression of GPC3 has been observed in several types of cancer, most notably hepatocellular carcinoma, where it is considered a diagnostic marker and a potential target for [[therapeutic antibodies]] and [[cancer vaccines]].

	== ~~Genetics~~ ==		=== Role in Cancer ===
	The ''GPC3'' gene is located on the X chromosome (Xq26). Mutations in this gene, including deletions and missense mutations, have been identified in patients with Simpson-Golabi-Behmel syndrome. These genetic alterations result in the production of a nonfunctional version of glypican 3 or lead to its complete absence, contributing to the syndrome's clinical features.

	~~== Diagnostic and Therapeutic Applications ==~~		Glypican-3 is overexpressed in several types of cancer, most notably [[hepatocellular carcinoma]] (HCC). It is considered a potential biomarker for the diagnosis and prognosis of HCC. The expression of GPC3 in tumors can be targeted for therapeutic purposes, including the development of GPC3-specific antibodies and [[chimeric antigen receptor T-cell\|CAR T-cell]] therapies.
	~~Due to its overexpression~~ in hepatocellular carcinoma ~~and other tumors, GPC3~~ is a biomarker for the diagnosis and prognosis of ~~these cancers~~. ~~Serum levels~~ of GPC3 can be ~~measured~~, ~~and its presence on~~ the ~~surface~~ of ~~tumor cells can be detected using immunohistochemistry~~. ~~Therapeutically, monoclonal antibodies targeting~~ GPC3 are ~~being developed~~ and ~~tested in clinical trials for~~ the ~~treatment~~ of ~~hepatocellular carcinoma and other~~ GPC3~~-positive tumors~~.
			=== Simpson-Golabi-Behmel Syndrome ===

			Mutations in the GPC3 gene are associated with [[Simpson-Golabi-Behmel syndrome]], a rare genetic disorder characterized by pre- and postnatal overgrowth, facial dysmorphism, and an increased risk of developing embryonal tumors. This syndrome highlights the importance of GPC3 in growth regulation.

	== Research Directions ==		== Research Directions ==
	Research on glypican 3 continues to explore its role in cancer biology, with a focus on understanding how its expression is regulated and how it interacts with other molecules and signaling pathways in the tumor microenvironment. Studies are also investigating the potential of GPC3-targeted therapies, including antibody-drug conjugates and CAR T-cell therapies, offering hope for new treatments for cancers with high GPC3 expression.

	[[Category:~~Proteins~~]]		Ongoing research is focused on understanding the precise molecular mechanisms by which GPC3 regulates growth factor signaling. Additionally, there is significant interest in developing GPC3-targeted therapies for cancer treatment, as well as exploring its role in other diseases.
	[[Category:~~Genes on human chromosome X~~]]
	[[Category:~~Cancer research~~]]		== Related Pages ==
	~~{{pharma-stub}}~~
			* [[Heparan sulfate proteoglycan]]
			* [[Hepatocellular carcinoma]]
			* [[Simpson-Golabi-Behmel syndrome]]
			* [[Wnt signaling pathway]]

			{{Glypicans}}
			{{Proteoglycans}}

			[[Category:Proteoglycans]]
			[[Category:Oncology]]
			[[Category:Developmental biology]]

Prab: CSV import

2024-03-30T03:59:50Z

CSV import

New page

'''Glypican 3''' ('''GPC3''') is a [[protein]] that in humans is encoded by the ''GPC3'' [[gene]]. It is a member of the [[glypican]] family, a group of [[heparan sulfate]] [[proteoglycans]] that are attached to the membrane by a [[Glycosylphosphatidylinositol|glycosylphosphatidylinositol]] (GPI) anchor. Glypican 3 plays a significant role in [[cell growth]], [[cell differentiation]], and [[cell division]], and is involved in the regulation of [[Wnt signaling pathway|Wnt signaling]] and [[Hedgehog signaling pathway|Hedgehog signaling]] pathways. These pathways are critical for normal [[embryonic development]] and have been implicated in the development of various [[cancer]]s when dysregulated.

== Function ==
Glypican 3 is primarily expressed in the [[liver]], [[kidney]], and [[lung]], and is involved in the modulation of cell growth and proliferation. It acts as a co-receptor for growth factors and modulates signaling pathways that are crucial for [[embryogenesis]] and [[organogenesis]]. In the liver, GPC3 has been shown to play a role in controlling [[cell proliferation]] and in the suppression of [[Hepatocellular carcinoma|hepatocellular carcinoma]] (HCC), the most common type of liver cancer.

== Clinical Significance ==
The loss of GPC3 function has been associated with [[Simpson-Golabi-Behmel syndrome]], a rare genetic condition characterized by pre- and postnatal overgrowth, [[facial dysmorphism]], and an increased risk of developing embryonal tumors, including [[Wilms' tumor]], hepatoblastoma, and neuroblastoma. Conversely, overexpression of GPC3 has been observed in several types of cancer, most notably hepatocellular carcinoma, where it is considered a diagnostic marker and a potential target for [[therapeutic antibodies]] and [[cancer vaccines]].

== Genetics ==
The ''GPC3'' gene is located on the X chromosome (Xq26). Mutations in this gene, including deletions and missense mutations, have been identified in patients with Simpson-Golabi-Behmel syndrome. These genetic alterations result in the production of a nonfunctional version of glypican 3 or lead to its complete absence, contributing to the syndrome's clinical features.

== Diagnostic and Therapeutic Applications ==
Due to its overexpression in hepatocellular carcinoma and other tumors, GPC3 is a biomarker for the diagnosis and prognosis of these cancers. Serum levels of GPC3 can be measured, and its presence on the surface of tumor cells can be detected using immunohistochemistry. Therapeutically, monoclonal antibodies targeting GPC3 are being developed and tested in clinical trials for the treatment of hepatocellular carcinoma and other GPC3-positive tumors.

== Research Directions ==
Research on glypican 3 continues to explore its role in cancer biology, with a focus on understanding how its expression is regulated and how it interacts with other molecules and signaling pathways in the tumor microenvironment. Studies are also investigating the potential of GPC3-targeted therapies, including antibody-drug conjugates and CAR T-cell therapies, offering hope for new treatments for cancers with high GPC3 expression.

[[Category:Proteins]]
[[Category:Genes on human chromosome X]]
[[Category:Cancer research]]
{{pharma-stub}}

Glypican 3 - Revision history

Prab: CSV import

Prab: CSV import